Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Milowsky MI, O'Donnell PH, Hoimes CJ, Petrylak DP, Flaig TW, Moon HH, Friedlander TW, Mar N, McKay RR, Srinivas S, Gravis G, Ramamurthy C, Bupathi M, Bracarda S, Wright P, Hepp Z, Carret AS, Yu Y, Dillon R, Kataria R, Beaumont JL, Purnajo I, Rosenberg JE. Milowsky MI, et al. Among authors: wright p. J Clin Oncol. 2024 Apr 20;42(12):1403-1414. doi: 10.1200/JCO.23.01547. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215355 Free PMC article. Clinical Trial.
Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab.
Morgans AK, Sonpavde GP, Shih V, Wright P, Hepp Z, Willmon CL, Chang NN, Mucha L, Naga SSB, Powles T. Morgans AK, et al. Among authors: wright p. Clin Genitourin Cancer. 2024 Nov 15;23(1):102270. doi: 10.1016/j.clgc.2024.102270. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39662152 Free article.
Quality of life, healthcare usage and finances of UK cancer survivors five years post-diagnosis: a matched controlled study.
Warrington L, Absolom K, Baxter P, Bojke C, Clarke G, Crossfield S, Johnston C, Martin A, McInerney CD, Saalmink G, Siciliano M, Stamp E, Velikova G, Wilkinson D, Woroncow B, Wright P, Zucker K, Hall G, Glaser A. Warrington L, et al. Among authors: wright p. J Cancer Surviv. 2024 Dec 3. doi: 10.1007/s11764-024-01708-x. Online ahead of print. J Cancer Surviv. 2024. PMID: 39627376 Free article.
3,550 results